Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
505.00    0.00 (0.00%)
Bid:
505.00
Ask:
505.50
Spread: 0.50 (0.099%)
Market Cap: £2.23b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

5 Aug 2025 07:00

RNS Number : 9010T
Tate & Lyle PLC
05 August 2025
 

Tate & Lyle PLC

 

Notification of transactions by Persons Discharging Managerial Responsibilities

 

Tate & Lyle PLC (the 'Company') has been informed that on 1 August 2025 the following transaction occurred by a Person Discharging Managerial Responsibilities ('PDMR') and a person closely associated ('PCA') in respect of their purchase of American Depositary Receipts ('ADRs'), where each ADR represents an interest in four (4) ordinary shares of 29 1/6 pence each in the capital of the Company ('Shares').

 

PDMR

Number of ADR's acquired

Price per ADR

Claudia Vaz de Lestapis (PDMR) and Alexandre Samuel Pierre Marie de Lestapis (PCA)

2,500

US$28.84

 

Following this purchase, Ms Vaz de Lestapis and Mr de Lestapis are interested in a total of 2,500 ADRs, representing 10,000 Shares.

 

The notification below, which has been made in accordance with the requirements of the Market Abuse Regulation, provide further detail.

 

Matthew Joy

Company Secretary

4 August 2025

 

 

Notification and public disclosure of transaction by person discharging managerial responsibilities

 

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Claudia Vaz de Lestapis (PDMR) and Alexandre Samuel Pierre Marie de Lestapis (PCA)

2.

Reason for the notification

a)

Position / status

Non-executive Director and a person closely associated

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tate & Lyle PLC

b)

LEI

2138008K14474WPKZ244

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

American Depositary Receipts ('ADRs') each of which represents four (4) Ordinary shares of 29 1/6 pence each in the capital of Tate & Lyle PLC

 

 

US8765706077

b)

Nature of the transaction

Acquisition of ADR's

c)

Price(s) and volume(s)

Price per ADR

Volume(s)

US$28.84

2,500

d)

Aggregated information

- Aggregated volume

- Price

 

 

2,500 ADRs

 

$72,100

e)

Date of the transaction

1 August 2025

f)

Place of the transaction

OTCQX exchange

OTCQX

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUSRVRVKUWRAR
Date   Source Headline
29th May 20185:54 pmBUSDirector/PDMR Shareholding
24th May 20187:00 amBUSFinal Results
1st May 20181:00 pmBUSTotal Voting Rights
18th Apr 201812:27 pmBUSDirector/PDMR Shareholding
17th Apr 20187:00 amBUSImran Nawaz Appointed Chief Financial Officer of Tate & Lyle PLC
13th Apr 20181:48 pmBUSDirector Declaration
5th Apr 20184:31 pmBUSDirector/PDMR Shareholding
4th Apr 20184:47 pmBUSDirector/PDMR Shareholding
3rd Apr 201812:27 pmBUSTotal Voting Rights
2nd Mar 201812:04 pmBUSDirector/PDMR Shareholding
15th Feb 20183:44 pmBUSDirector/PDMR Shareholding
14th Feb 20182:55 pmBUSDirector/PDMR Shareholding
13th Feb 20182:03 pmBUSDirector/PDMR Shareholding
8th Feb 20187:00 amBUSTrading Statement
1st Feb 20183:38 pmBUSTotal Voting Rights
18th Jan 20184:12 pmBUSHolding(s) in Company
16th Jan 20187:00 amBUSNick Hampton Appointed Chief Executive of Tate & Lyle PLC
2nd Jan 20189:34 amBUSBlock listing Interim Review
8th Dec 20172:39 pmBUSDirector Declaration
4th Dec 20171:40 pmBUSDirector/PDMR Shareholding
24th Nov 201712:54 pmBUSDirector/PDMR Shareholding
20th Nov 20173:21 pmBUSHolding(s) in Company
16th Nov 20171:17 pmBUSHolding(s) in Company
13th Nov 20171:08 pmBUSHolding(s) in Company
2nd Nov 20177:00 amBUSHalf-year Report
1st Nov 20175:00 pmBUSHolding(s) in Company
19th Sep 20174:16 pmBUSHolding(s) in Company
13th Sep 201710:00 amBUSDirector/PDMR Shareholding
1st Sep 201710:00 amBUSTotal Voting Rights
17th Aug 201711:38 amBUSDirector/PDMR Shareholding
9th Aug 20174:00 pmBUSDirectorate change
3rd Aug 201711:00 amBUSResult of the External Audit Tender
27th Jul 20172:37 pmBUSResult of AGM
27th Jul 20177:00 amBUSTrading Statement
3rd Jul 201712:35 pmBUSTotal Voting Rights
3rd Jul 201712:34 pmBUSBlock listing Interim Review
30th Jun 20173:36 pmBUSDirector/PDMR Shareholding
29th Jun 20173:37 pmBUSDirector/PDMR Shareholding
26th Jun 20173:40 pmBUSDirector/PDMR Shareholding
19th Jun 20174:21 pmBUSAnnual Financial Report
16th Jun 20174:20 pmBUSDirector/PDMR Shareholding
14th Jun 20174:31 pmBUSHolding(s) in Company
1st Jun 20173:40 pmBUSTotal Voting Rights
31st May 20173:11 pmBUSHolding(s) in Company
26th May 201711:40 amBUSHolding(s) in Company
25th May 20177:00 amBUSFinal Results
18th May 20172:40 pmBUSHolding(s) in Company
2nd May 201711:55 amBUSTotal Voting Rights
26th Apr 201710:52 amBUSHolding(s) in Company
11th Apr 20175:05 pmBUSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.